Related Experiment Video

Updated: Aug 1, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.8K

PI3K Functions Downstream of Cdc42 to Drive Cancer phenotypes in a Melanoma Cell Line

Rosemary Poku1, Felix Amissah2, Jamie K Alan3

  • 1College of Medicine, Central Michigan University, Mt. Pleasant, MI, USA.

Small Gtpases
|April 28, 2023
PubMed

Insights

Activating mutations in Cdc42 (a Rho family GTPase) drive melanoma growth. Inhibiting PI3K effectively blocks Cdc42-driven cancer phenotypes, suggesting PI3K as a key therapeutic target in melanoma.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Rho proteins, including Cdc42 (a Rho family GTPase), regulate cytoskeletal dynamics, impacting cell adhesion and motility.
  • Activating Cdc42 mutations are implicated in melanoma, and PI3K signaling is known to be downstream of activated Cdc42.

Purpose of the Study:

  • To investigate the role of PI3K as a downstream signaling partner of Cdc42 in a BRAF-mutated melanoma cell line.
  • To determine if PI3K inhibition can counteract Cdc42-driven melanoma phenotypes.

Main Methods:

  • Utilized a melanoma cell line harboring a BRAF mutation.
  • Assessed the effects of Cdc42 activity on proliferation, anchorage-independent growth, motility, and invasion.
  • Administered a pan-PI3K inhibitor to evaluate its impact on cancer phenotypes.

Main Results:

  • Cdc42 was found to significantly contribute to melanoma cell proliferation, anchorage-independent growth, motility, and invasion.
  • Treatment with a pan-PI3K inhibitor effectively ameliorated all observed cancer-associated phenotypes driven by Cdc42.
  • These findings highlight the critical role of PI3K signaling in mediating Cdc42's oncogenic functions in melanoma.

Conclusions:

  • PI3K is a crucial downstream effector of Cdc42 in melanoma cells with BRAF mutations.
  • Targeting PI3K represents a promising therapeutic strategy for melanoma patients with Cdc42 pathway activation.
Keywords:
Cdc42PI3KRho GTPasesmelanoma

More Related Videos

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

945
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K